Ontology highlight
ABSTRACT:
SUBMITTER: Baek M
PROVIDER: S-EPMC11008899 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature

Baek Mina M Kim Minjae M Choi Hae In HI Binas Bert B Cha Junho J Jung Kyoung Hwa KH Choi Sungkyoung S Chai Young Gyu YG
PloS one 20240411 4
The multikinase inhibitor sorafenib is the standard first-line treatment for advanced hepatocellular carcinoma (HCC), but many patients become sorafenib-resistant (SR). This study investigated the efficacy of another kinase inhibitor, regorafenib (Rego), as a second-line treatment. We produced SR HCC cells, wherein the PI3K-Akt, TNF, cAMP, and TGF-beta signaling pathways were affected. Acute Rego treatment of these cells reversed the expression of genes involved in TGF-beta signaling but further ...[more]